Target intelligence / Profile preview

T cell receptor gamma variable 6 pseudogene (TRGV6)

Target: TRGV6
Molecular classification: Pseudogene, Immunoglobulin superfamily (as a locus/family member), Component of the T cell receptor (gamma chain variable region)

Overview

T cell receptor gamma variable 6 (TRGV6) is a member of the T cell receptor gamma (TRG) variable gene family, specifically annotated as a pseudogene in humans. The T cell receptor gamma variable (TRGV) genes encode variable segments of the gamma chain of the T cell receptor, which participates in antigen recognition by γδ T cells. However, TRGV6 is classified as a pseudogene, meaning it contains sequence features that prevent it from being a functional protein-coding gene, and is not translated into a functional receptor chain. It is best understood as a genetic relic with no current biological or clinical relevance as a therapeutic target, drug interaction site, or disease biomarker.

Other names: V1S5PTCRGV5PT-cell receptor, gamma, variable region V5P (pseudogene)

Mechanism of action

None (not druggable; not expressed as a functional protein)

Biological functions

None (TRGV6 is a pseudogene and not known to be functionally transcribed or translated; functional TRGV genes encode the variable region of the T cell receptor gamma chain involved in antigen recognition)

Disease associations

None (no evidence this specific pseudogene is implicated in disease)

Safety considerations

None (not a drug target; not expressed as protein)

Interacting drugs

None (no interacting drugs because it is a pseudogene and does not encode a targetable protein)

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on T cell receptor gamma variable 6 pseudogene (TRGV6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor gamma variable 6 pseudogene (TRGV6).

Explore the full profile